Prospective association of childhood attention-deficit/hyperactivity disorder (ADHD) and substance use and abuse/dependence: A meta-analytic review

被引:569
|
作者
Lee, Steve S. [1 ]
Humphreys, Kathryn L. [1 ]
Flory, Kate [2 ]
Liu, Rebecca [1 ]
Glass, Kerrie [2 ]
机构
[1] Univ Calif Los Angeles, Dept Psychol, Los Angeles, CA 90095 USA
[2] Univ S Carolina, Dept Psychol, Columbia, SC 29208 USA
关键词
ADHD; Substance; Prospective longitudinal; DEFICIT HYPERACTIVITY DISORDER; PROSPECTIVE FOLLOW-UP; POOR RESPONSE-INHIBITION; DSM-IV DISORDERS; CONDUCT DISORDER; CIGARETTE-SMOKING; YOUNG-ADULTS; PSYCHOSTIMULANT TREATMENT; BEHAVIORAL DISINHIBITION; PSYCHIATRIC-DISORDER;
D O I
10.1016/j.cpr.2011.01.006
中图分类号
B849 [应用心理学];
学科分类号
040203 ;
摘要
Given the clinical and public health significance of substance disorders and the need to identify their early risk factors, we examined the association of childhood attention-deficit/hyperactivity disorder (ADHD) with substance use (nicotine, alcohol, marijuana) and abuse/dependence outcomes (nicotine, alcohol, marijuana, cocaine, other). To strengthen a potential causal inference, we meta-analyzed longitudinal studies that prospectively followed children with and without ADHD into adolescence or adulthood. Children with ADHD were significantly more likely to have ever used nicotine and other substances, but not alcohol. Children with ADHD were also more likely to develop disorders of abuse/dependence for nicotine, alcohol, marijuana, cocaine, and other substances (i.e., unspecified). Sex, age, race, publication year, sample source, and version of the Diagnostic and Statistical Manual of Mental Disorders (DSM) used to diagnose ADHD did not significantly moderate the associations with substance outcomes that yielded heterogeneous effect sizes. These findings suggest that children with ADHD are significantly more likely to develop substance use disorders than children without ADHD and that this increased risk is robust to demographic and methodological differences that varied across the studies. Finally, few studies addressed ADHD and comorbid disruptive behavior disorders (DBD), thus preventing a formal meta-analytic review. However, we qualitatively summarize the results of these studies and conclude that comorbid DBD complicates inferences about the specificity of ADHD effects on substance use outcomes. (C) 2011 Elsevier Ltd. All rights reserved.
引用
收藏
页码:328 / 341
页数:14
相关论文
共 50 条
  • [41] Childhood attention-deficit/hyperactivity disorder
    Verkuijl, Nienke
    Perkins, Marian
    Fazel, Mina
    BMJ-BRITISH MEDICAL JOURNAL, 2015, 350 : h2168
  • [42] Prevalence of attention-deficit hyperactivity disorder (ADHD): systematic review and meta-analysis
    Popit, Sara
    Serod, Klara
    Locatelli, Igor
    Stuhec, Matej
    EUROPEAN PSYCHIATRY, 2024, 67 (01)
  • [43] Substance abuse in patients with attention-deficit hyperactivity disorder - Therapeutic implications
    Schubiner, H
    CNS DRUGS, 2005, 19 (08) : 643 - 655
  • [44] What is attention-deficit hyperactivity disorder (ADHD)?
    Furman, L
    JOURNAL OF CHILD NEUROLOGY, 2005, 20 (12) : 994 - 1002
  • [45] FORETHOUGHT IN ATTENTION-DEFICIT HYPERACTIVITY DISORDER (ADHD)
    Poissant, Helene
    Mendrek, Adrianna
    Rapin, Lucile
    Senhadji, Noureddine
    JOURNAL OF COGNITIVE NEUROSCIENCE, 2013, : 160 - 160
  • [46] Genetics of attention-deficit hyperactivity disorder (ADHD)
    Sharp, Sally I.
    McQuillin, Andrew
    Gurling, Hugh M. D.
    NEUROPHARMACOLOGY, 2009, 57 (7-8) : 590 - 600
  • [48] Attention-deficit/hyperactivity disorder (ADHD) at the workplace
    Stockreiter, D.
    Reuss, F.
    Holzgreve, F.
    Germann, U.
    Oremek, G.
    Ohlendorf, D.
    Wanke, E. M.
    ZENTRALBLATT FUR ARBEITSMEDIZIN ARBEITSSCHUTZ UND ERGONOMIE, 2024, 74 (05): : 234 - 240
  • [50] Attention-deficit/hyperactivity disorder (ADHD) as a noradrenergic disorder
    Biederman, J
    Spencer, T
    BIOLOGICAL PSYCHIATRY, 1999, 46 (09) : 1234 - 1242